SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-22-004491
Filing Date
2022-03-01
Accepted
2022-03-01 16:08:34
Documents
76
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nltx-20211231.htm   iXBRL 10-K 1490627
2 EX-10.19 exhibit1019-neoleukinuwame.htm EX-10.19 22855
3 EX-10.21 exhibit1021-employmentagre.htm EX-10.21 80333
4 EX-21.2 exhibit211-listofsubsidiar.htm EX-21.2 2493
5 EX-23.1 exhibit231-consentofindepe.htm EX-23.1 2489
6 EX-31.1 exhibit3112021ye.htm EX-31.1 9499
7 EX-31.2 exhibit3122021ye.htm EX-31.2 9562
8 EX-32.1 exhibit3212021ye.htm EX-32.1 6856
  Complete submission text file 0001628280-22-004491.txt   6283483

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nltx-20211231.xsd EX-101.SCH 42593
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nltx-20211231_cal.xml EX-101.CAL 73920
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nltx-20211231_def.xml EX-101.DEF 148731
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nltx-20211231_lab.xml EX-101.LAB 561186
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nltx-20211231_pre.xml EX-101.PRE 349662
70 EXTRACTED XBRL INSTANCE DOCUMENT nltx-20211231_htm.xml XML 826797
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36327 | Film No.: 22698013
SIC: 2834 Pharmaceutical Preparations